Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome

Hormone and Metabolic Research

Volumn 43, Issue 9, 2011, Pages 642-645

  Kim, H R ^a   Lee, S A ^a   Kim, H J ^b   Kong, M H ^b   Kim, Y R ^b   Kang, S H ^b   Lee, K H ^b   Leng, L ^c   Lee, B J ^d   Park, C G ^a   Kook, Y H ^a   Kim, B J ^a   Bucala, R ^c  

^a Seoul National University   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Sungkyunkwan University   (South Korea)

Author keywords

cytokines; human; metabolic syndrome; MIF

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX FACTORS;

EID: 80051791384     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1283150     Document Type: Article

References (21)

1. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr: 1956; 4 20 34
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes: 1988; 37 1595 1607 (Pubitemid 19004941)
3. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol: 2003; 3 791 800 (Pubitemid 37328657)
4. Morand EF, Leech M, Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov: 2006; 5 399 410
5. Zernecke A, Bernhagen J, Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation: 2008; 117 1594 1602 (Pubitemid 351440647)
6. Atsumi T, Cho YR, Leng L, McDonald C, Yu T, Danton C, Hong EG, Mitchell RA, Metz C, Niwa H, Takeuchi J, Onodera S, Umino T, Yoshioka N, Koike T, Kim JK, Bucala R. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol: 2007; 179 5399 5406
7. Verschuren L, Kooistra T, Bernhagen J, Voshol PJ, Ouwens DM, van Erk M, de Vries-van der Weij J, Leng L, van Bockel JH, van Dijk KW, Fingerle-Rowson G, Bucala R, Kleemann R. MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res: 2009; 105 99 107
8. Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators Inflamm. 2010; 610479
9. Noels H, Bernhagen J, Weber C. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis. Trends Cardiovasc Med: 2009; 19 76 86
10. Herder C, Kolb H, Koenig W, Haastert B, Muller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care: 2006; 29 368 371 (Pubitemid 44106520)
11. Aslani S, Hossein-Nezhad A, Maghbooli Z, Mirzaei K, Karimi F. Genetic Variation in Macrophage Migration Inhibitory Factor Associated with Gestational Diabetes Mellitus and Metabolic Syndrome. Horm Metab Res April 21 [Epub ahead of print]
12. Herder C, Klopp N, Baumert J, Muller M, Khuseyinova N, Meisinger C, Martin S, Illig T, Koenig W, Thorand B. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 19842002. Diabetologia: 2008; 51 276 284
13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA: 2002; 287 356 359 (Pubitemid 34251969)
14. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med: 2007; 4 Suppl B S162 S177
15. Burger-Kentischer A, Goebel H, Seiler R, Fraedrich G, Schaefer HE, Dimmeler S, Kleemann R, Bernhagen J, Ihling C. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation: 2002; 105 1561 1566 (Pubitemid 34297633)
16. Vozarova B, Stefan N, Hanson R, Lindsay RS, Bogardus C, Tataranni PA, Metz C, Bucala R. Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia: 2002; 45 1739 1741 (Pubitemid 35478148)
17. Makino A, Nakamura T, Hirano M, Kitta Y, Sano K, Kobayashi T, Fujioka D, Saito Y, Watanabe K, Watanabe Y, Kawabata K, Obata JE, Kugiyama K. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus. Atherosclerosis: 2010; 213 573 578
18. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol: 2006; 95 136 147
19. Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M, Burow M, Horan MA, Wahl SM, Nakayama T. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest: 2003; 111 1309 1318 (Pubitemid 36554701)
20. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res: 2002; 57 257 275
21. Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Boon WC, Simpson ER, Davis SR. Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause: 2005; 12 210 215 (Pubitemid 40464290)